Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2025-01-02 · accession 0001649094-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-03 | 2025-01-02 | PCVX | Wassil Jim | COO | S - Sale+OE | $83.66 | -8,000 | 205.7K | -4% | -$669.3K |
| D | 2025-01-03 | 2025-01-02 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| D | 2025-01-03 | 2025-01-02 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -8,000 | 10.6K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-02 | S | D | 5,483 | $83.69 | 206,856 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $83.31 to $84.215. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-01-02 | S | D | 1,356 | $82.88 | 212,339 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $82.31 to $83.265. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-01-02 | M | A | 8,000 | $2.42 | 213,695 | D | — | — | |
| 4 | Common | Common Stock | 2025-01-02 | S | D | 1,161 | $84.43 | 205,695 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $84.315 to $84.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2025-01-02 | M | D | 8,000 | $0.00 | 10,638 | D | $2.42 · — to 2029-12-16 | 8,000 Common Stock | (F5) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |